Breaking News
Sort by:
Top Post
New Two-year Data Confirm Roche’s Vabysmo Improves Vision With Fewer Treatments for People With Neovascular Age-related Macular Degeneration
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new two-year data from the TENAYA and […]
Malaysian Genomics Grows Presence in Thailand
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is […]
Freenome Launches Its First Study for the Detection of Multiple Cancers That Pairs Multiomics With Real-World Data
Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the […]
DotLab Announces Three Granted Patents for Its Non-invasive Test for Endometriosis, DotEndo™
DotLab, a medical diagnostics company, announced that the United States Patent and Trademark Office has […]
Pediatric Medical Centers Improve the Efficiency of Investigator-Initiated, Multi-Site, Collaborative Research with TriNetX
TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of […]
Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform
Rona Therapeutics, Inc (“Rona”), a fully integrated platform company dedicated to the discovery, development and […]
Key Developments Reinvigorate the Insulin Pump Industry, Finds IDTechEx Report
IDTechEx Cambridge, UK Insulin pumps offer several prominent benefits over other insulin delivery methods. Insulin […]
Concord Health Partners Expands Senior Team & Opens Nashville Office
Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]
Researchers Create a Single-cell Framework to Potentially Enhance CAR T-cell Therapy
St. Jude Children’s Research Hospital scientists have demonstrated that the long-term performance of cancer-killing chimeric […]
Statement from Steve Barclay, Secretary of State for Health and Social Care
Health and Social Care Secretary Steve Barclay said: It is an honour to take up […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more